Disruption of IGF signaling in early hepatocellular carcinoma and pre-clinical efficacy of anti-IGF1R blocking therapies

被引：1
|
作者：
Tovar, V. [1 ,2 ]
Alsinet, C. [1 ,2 ]
Cabellos, L. [1 ,2 ]
Sole, M. [1 ,2 ]
Villanueva, A. [3 ]
Chiang, D. [5 ]
Moyano, S. [1 ,2 ]
Schwartz, M. [3 ]
Mazzaferro, V. [4 ]
Bruix, J. [1 ,2 ]
Llovet, J. M. [1 ,2 ,3 ]
机构：
[1] IDIBAPS, Hosp Clin, Liver Unit, HCC Translat Lab,BCLC Grp, Barcelona, Spain
[2] IDIBAPS, Hosp Clin, Dept Pathol, Barcelona, Spain
[3] Mt Sinai Sch Med, Div Liver Dis, Mt Sinai Liver Canc Program, New York, NY USA
[4] Ist Nazl Tumori, I-20133 Milan, Italy
[5] Broad Inst, Canc Program, Boston, MA USA
来源：
JOURNAL OF HEPATOLOGY | 2008年 / 48卷
关键词：
D O I：
10.1016/S0168-8278(08)60004-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [31] Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody
    Chapuis, Nicolas
    Tamburini, Jerome
    Cornillet-Lefebvre, Pascale
    Gillot, Lucile
    Bardet, Valerie
    Willems, Lise
    Park, Sophie
    Green, Alexa S.
    Ifrah, Norbert
    Dreyfus, Francois
    Mayeux, Patrick
    Lacombe, Catherine
    Bouscary, Didier
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (03): : 415 - 423
  • [32] Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma
    El Tayebi, Hend M.
    Waly, Amr A.
    Assal, Reem A.
    Hosny, Karim A.
    Esmat, Gamal
    Abdelaziz, Ahmed I.
    ONCOLOGY LETTERS, 2015, 10 (05) : 3206 - 3212
  • [33] Expression of GRK2 and IGF1R in hepatocellular carcinoma: clinicopathological and prognostic significance
    Lin, Song-Bai
    Zhou, Li
    Liang, Zhi-Yong
    Zhou, Wei-Xun
    Jin, Ye
    JOURNAL OF CLINICAL PATHOLOGY, 2017, 70 (09) : 754 - 759
  • [34] CBX1 is involved in hepatocellular carcinoma progression and resistance to sorafenib and lenvatinib via IGF-1R/AKT/SNAIL signaling pathway
    Zheng, Su-Su
    Wu, Jing-Fang
    Wu, Wei-Xun
    Hu, Jin-Wu
    Zhang, Dai
    Huang, Cheng
    Zhang, Bo-Heng
    HEPATOLOGY INTERNATIONAL, 2024, 18 (05) : 1499 - 1515
  • [35] NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia
    Renata Scopim-Ribeiro
    João Agostinho Machado-Neto
    Christopher A. Eide
    Juan Luiz Coelho-Silva
    Bruna Alves Fenerich
    Jaqueline Cristina Fernandes
    Priscila Santos Scheucher
    Samantha L. Savage Stevens
    Paula de Melo Campos
    Sara T. Olalla Saad
    Leonardo de Carvalho Palma
    Lorena Lobo de Figueiredo-Pontes
    Belinda Pinto Simões
    Eduardo Magalhães Rego
    Cristina E. Tognon
    Brian J. Druker
    Fabiola Traina
    Investigational New Drugs, 2021, 39 : 736 - 746
  • [36] OVEREXPRESSION OF BACH1 MEDIATED BY IGF2 FACILITATES HEPATOCELLULAR CARCINOMA GROWTH AND METASTASIS VIA IGF1R AND PTK2
    Xia, Limin
    GASTROENTEROLOGY, 2022, 162 (07) : S1183 - S1184
  • [37] Overexpression of BACH1 mediated by IGF2 facilitates hepatocellular carcinoma growth and metastasis via IGF1R and PTK2
    Xie, Meng
    Sun, Mengyu
    Ji, Xiaoyu
    Li, Dongxiao
    Chen, Xiaoping
    Zhang, Bixiang
    Huang, Wenjie
    Zhang, Tongyue
    Wang, Yijun
    Tian, Dean
    Xia, Limin
    THERANOSTICS, 2022, 12 (01): : 1097 - 1116
  • [38] NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia
    Scopim-Ribeiro, Renata
    Machado-Neto, Joao Agostinho
    Eide, Christopher A.
    Coelho-Silva, Juan Luiz
    Fenerich, Bruna Alves
    Fernandes, Jaqueline Cristina
    Scheucher, Priscila Santos
    Stevens, Samantha L. Savage
    Campos, Paula de Melo
    Olalla Saad, Sara T.
    Palma, Leonardo de Carvalho
    de Figueiredo-Pontes, Lorena Lobo
    Simoes, Belinda Pinto
    Rego, Eduardo Magalhaes
    Tognon, Cristina E.
    Druker, Brian J.
    Traina, Fabiola
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (03) : 736 - 746
  • [39] CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy
    Ran Rostoker
    Sarit Ben-Shmuel
    Rola Rashed
    Zila Shen Orr
    Derek LeRoith
    Breast Cancer Research, 18
  • [40] Functional characterization of IGF-1R antibodies and possible implications for clinical safety and efficacy
    Kuenkele, Klaus-Peter
    Hofmann, Marco H.
    Scheiblich, Stefan
    Wartha, Katharina
    Klein, Christian
    CANCER RESEARCH, 2011, 71
12345